Simultaneous adsorption and oxidation of Sb(III) from water by the pH-sensitive superabsorbent polymer hydrogel incorporated with Fe-Mn binary oxides composite

In this work, the superabsorbent polymer hydrogel (SPH) of Poly(potassium acrylate-co-acrylamide (PPAA)) incorporated with Fe-Mn binary oxides (FMBOs) was synthesized and used for the removal of Sb(III) from water. Characterization analysis proved that FMBO₃ was successfully encapsulated into the SPH. The Fe/Mn oxide species in the composite SPH comprised FeO(OH), Fe₂O₃, MnO(OH), and MnO₂. The functional groups including N-H, -OH, carboxy as well as Fe atoms were confirmed adsorption sites through ligand exchange and inner-sphere complexes formation. Mn oxides can partially oxidize Sb(III) to Sb(V). Compared with the pseudo-first-order model, the pseudo-second-order model could better describe the adsorption kinetics. And the swelling degree of the composite SPH had a positive impact on the removal rate. The Langmuir-Freundlich model was the most suitable isotherm model to analyze the experimental data. According to thermodynamic parameters, the adsorption process was a spontaneous exothermic reaction. The maximum adsorption capacity of the composite SPH for Sb(III) could be up to 105.59 mg/g at 288 K. In addition, a stable removal rate can be achieved over a wide pH range of 3-10, with little metal leaching even under acidic conditions. Furthermore, coexisting ions and DOM displayed an insignificant influence on the adsorption of Sb(III).

Enhanced removal of oxytetracycline antibiotics from water using manganese dioxide impregnated hydrogel composite: Adsorption behavior and oxidative degradation pathways

The present work provides the first attempt of using manganese dioxide loaded poly(sodium acrylate) hydrogel (MnO₂@PSA) to address potential threats posed by oxytetracycline (OTC) antibiotics in aqueous environment. The MnO₂@PSA was prepared via a facile approach and demonstrated enhanced removal performance even under extremely high concentrations of OTC. The outstanding performance exhibited by MnO₂@PSA was attributed to synergetic effects of adsorption oxidative degradation. The synthesized composite was characterized evaluated under varying conditions. The adsorption pH was optimized at pH 5, at which the removal efficiency OTC was reached 91.46%. According to the kinetics study, the pseudo-second-order kinetic model was the best to explain the adsorption data, implying the interaction mechanisms were dominated by chemisorption. The Langmuir isotherm model was the best to explain the isotherm data, and the corresponding maximum adsorbed amount of OTC was 1150.4 mg g^-1. The MnO₂@PSA was highly selective for OTC adsorption and degradation under the presence of natural organic matter and common environmental metal ions. The oxidative degradation study indicated that OTC molecules were structurally degraded into 15 intermediate products via six reaction pathways. Both the theoretical models and spectroscopic methods demonstrated the removal mechanism of OTC onto MnO₂@PSA was governed by ion exchange, cation-π bonding, hydrogen-bonding, and π-π electron donor-acceptor. Overall, MnO₂@PSA is an excellent and environmentally sustainable material to remove OTC from water and wastewater via the combined effects of adsorption and oxidative degradation.

Hydrous manganese dioxide modified poly(sodium acrylate) hydrogel composite as a novel adsorbent for enhanced removal of tetracycline and lead from water

In this study, hydrous manganese dioxide (HMO) modified poly(sodium acrylate) (PSA) hydrogel was produced for the first time to remove tetracycline(TC) and lead(Pb(II)) from water. The as-prepared composite was characterized using various techniques, such as SEM-EDS, FTIR, XRD, BET, and XPS, to elucidate the successful loading of HMO and analyze subsequent sorption mechanisms. Different influencing parameters such as adsorbent dose, initial concentration of adsorbates, reaction time, solution pH, and temperature were also investigated. The adsorption kinetic studies of both TC and Pb(II) removal indicated that equilibrium was achieved within 12 h, with respective removal rates of 91.9 and 99.5%, and the corresponding adsorption data were fitted to the second-order kinetics model. According to the adsorption isotherm studies, the sorption data of TC best fitted to the Langmuir isotherm model while the adsorption data of Pb(II) were explained by the Freundlich isotherm model. The maximum adsorption capacities of both TC and Pb(II) were found to be 475.8 and 288.7 mg/g, respectively, demonstrating excellent performances of the adsorbent. The uptake capacity of PSA-HMO was significantly influenced by the level of solution pH, in which optimum adsorption amount was realized at pH 4.0 in the TC and Pb(II) systems, respectively. Thermodynamic studies showed the process of TC and Pb(II) adsorptions were endothermic and spontaneous. Overall this study elucidated that PSA-HMO composite can be a promising candidate for antibiotics and heavy metal removal in water treatment applications.

Evaluating the effect of fenton pretreated pyridine wastewater under different biological conditions: Microbial diversity and biotransformation pathways

Pyridine contamination poses a significant threat to human and environmental health. Due to the presence of nitrogen atom in the pyridine ring, the pi bond electrons are attracted toward it and make difficult for pyridine treatment with biological and chemical methods. In this study, coupling Fenton treatment with different biological process was designed to enhance pyridine biotransformation and further mineralization. After Fenton oxidation process optimized, pretreated pyridine was evaluated under three biological (anaerobic, aerobic and microaerobic) operating conditions. Under optimum Fenton oxidation, pyridine (30-75%) and TOC (5-25%) removal efficiencies were poor. Biological process alone also showed insignificant removal efficiency, particularly anaerobic (pyridine = 8.2%; TOC = 5.3%) culturing condition. However, combining Fenton pretreatment with biological process increased pyridine (93-99%) and TOC (87-93%) removals, suggesting that hydroxyl radical generated during Fenton oxidation enhanced pyridine hydroxylation and further mineralization in the biological (aerobic > microaerobic > anaerobic) process. Intermediates were analyzed with UPLC-MS and showed presence of maleic acid, pyruvic acid, glutaric dialdehyde, succinic semialdehyde and 4-formylamino-butyric acid. High-throughput sequencing analysis also indicated that Proteobacteria (35-43%) followed by Chloroflexi (10.6-24.3%) and Acidobacteria (8.0-29%) were the dominant phyla detected in the three biological treatment conditions. Co-existence of dominant genera under aerobic/microaerobic (Nitrospira > Dokdonella > Caldilinea) and anaerobic (Nitrospira > Caldilinea > Longilinea) systems most probably play significant role in biotransformation of pyridine and its intermediate products. Overall, integrating Fenton pretreatment with different biological process is a promising technology for pyridine treatment, especially the combined system enhanced anaerobic (>10 times) microbial pyridine biotransformation activity.

Application of graphene-based materials for removal of tetracyclines using adsorption and photocatalytic-degradation: A review

Tetracyclines are extensively used to treat human and animal infectious diseases due to its effective antimicrobial activities. About 70-90% of its parent materials are released into the environment through urine and feces, implying they are the most frequently detected antibiotics in the environment with high ecological risks. Adsorption and photocatalysis have been promising techniques for the removal of tetracyclines due to effectiveness and efficiency. Graphene-based materials provide promising platforms for adsorptive and photocatalytic removal of tetracyclines from aqueous environment owning to distinctive remarkable physicochemical, optical, and electrical characteristics. Herein, we intensively reviewed the available literatures in order to provide comprehensive insight about the applications and mechanisms of graphene-based materials for removal of tetracyclines via adsorption and phototocatalysis. The synthesis methods of graphene-based materials, the tetracycline adsorption and photocatalytic-degradation conditions, and removal mechanisms have been extensively discussed. Finally concluding remarks and future perspectives have been deduced and recommended to stimulate further researches in the subject. The review study can be used as theoretical guideline for further researchers to improve the current approaches of material synthesis and application towards tetracyclines removal.

LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

Background

Hypercholesterolemia is a major risk factor for cardiovascular disorders and requires specific intervention through an adequate lifestyle (diet and physical exercise) and, if necessary, an appropriate drug treatment. Lipid-lowering drugs, although generally efficacious, may sometimes cause adverse events. A growing attention has been devoted to the correction of dyslipidemias through the use of dietary supplements. The aim of this study was to assess the lipid-lowering activity and safety of a dietary supplement containing monacolin K, L-arginine, coenzyme Q10 and ascorbic acid, named Argicolina (A), compared to a commercially available product containing monacolin K and coenzyme Q10, Normolip 5 (N).

Methods

This was a single center, controlled, randomized, open-label, cross-over clinical study enrolling 20 Caucasian outpatients aged 18–75 years with serum LDL-C between 130 and 180 mg/dL. Patients assumed two different dietary supplements (A and N) both containing monacolin K 10 mg for 8 weeks each, separated by a 4-week wash-out period. Evaluated parameters were: Total cholesterol (Tot-C), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting blood glucose, aspartate aminotransferase, alanine aminotransferase, creatinekinase, gamma-glutamyl-transpeptidase, brachial arterial pressure and heart rate, measured at the start and at the end of each treatment period. Safety was monitored through the study.

Results

LDL-C decreased by 23.3% during treatment with N (p < 0.0001) and by 25.6% during treatment with A (p < 0.0001); the LDL-C mean reduction was 36.4 (95% CI: 45,6–27,1) mg/dL during N treatment and 40.1 (95% CI: 49.2–30,9) mg/dL during A treatment. Tot-C decreased significantly (p < 0.0001) within each treatment period. HDL-C increase was negligible during A whereas it was significant during N. TG diminished markedly during A and not significantly during N. The difference between treatments was not statistically significant for all variables. No serious or severe adverse events occurred during the study.

Conclusions

Our results confirm the clinically meaningful LDL-C lowering properties of monacolin K. At variance with a supplement already in the market (N), the novel association (A) of monacolin K with L-arginine, coenzime Q10 and ascorbic acid also produces a significant reduction of triglycerides without significant effects on HDL.

Trial registration

ClinicalTrials.gov ID: NCT03425630.

The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats

In this study, the temporal development of focal cerebral infarction induced by permanent middle cerebral artery occlusion (pMCAO) and the effects of piracetam, a derivative of gamma-aminobutyric acid widely used in clinical practice as a nootropic agent, on infarct area and volume were investigated. pMCAO caused a cerebral infarct whose size progressively increased after 3, 6, 9, and 24 h. Piracetam (125 mg/kg i.p.), administered 6, 9, and 22 h after pMCAO, did not reduce pMCAO-induced brain infarct area size detected at the 24th hour. By contrast, when this agent was administered at the doses of 250 and 500 mg/kg, it caused a marked reduction of the infarct area size. This reduction was observed in almost every brain slice affected by pMCAO, although statistical differences (p <0.05) were detected in slices located at 3-5.5 mm posterior to the anterior pole in animals treated with 250 mg/kg piracetam and in slices located at 3.5-5 mm in those receiving 500 mg/kg. When the mean total volumes of brain infarct resulting from pMCAO were calculated, it was observed that in animals which had received piracetam (250 or 500 mg/kg) infarction volume was markedly ( approximately 50%) and significantly (p <0.05) reduced in comparison with saline injected rats. Finally, piracetam (250 mg/kg administered i.p. 6, 9, and 22 h after the ischemic insult) significantly reduced brain infarct area evaluated 48 h and 7 days after pMCAO.

[Behavioral states. An in utero study]

OBJECTIVE

This study aims to show how a single linear transducer and different state variables can be used to enable accurate identification of behavioural states.

DESIGN

Prospective observation study.

SETTING

Clinic of Obstetrics and Gynaecology III at the "Federico II" University of Naples.

SUBJECTS

Fifteen fetuses of women hospitalized in the Clinic of Gynaecology at the "Federico II" University of Naples at the end of a full-term, uncomplicated, single pregnancy with a reliably dated last menstruation.

METHODS

Ultrasound observation, registration and data processing of various fetal activities in the uterus mouth movements (sucking), other mouth movements, eye movements, gross body movements.

RESULTS

The fetal activities identified correspond exactly to the criteria established for the definition of state variables. An examination of the data thus obtained shows an inverse correlation between mouth movements and the other activities, and a direct correlation between the other three variables we considered.

CONCLUSIONS

The results obtained in our study show that this method can be profitably used to identify the behavioural states, in full-term, uncomplicated pregnancies.